IFRX vs REGN: Which Stock is Better?
Side-by-side comparison of Inflarx Nv and Regeneron Pharmaceuticals Inc in 2026
IFRX
Inflarx Nv
$1.07
REGN
Regeneron Pharmaceuticals Inc
$755.51
Key Metrics Comparison
| Metric | IFRX | REGN | Winner |
|---|---|---|---|
| Market Cap | $77.35M | $78.92B | REGN |
| P/E Ratio | N/A | 17.99 | REGN |
| EPS (TTM) | $N/A | $41.50 | REGN |
| Revenue Growth | -0.8% | 0.0% | REGN |
| Gross Margin | -24677.9% | 44.6% | REGN |
Analyze IFRX
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IFRX or REGN a better investment?
Comparing IFRX and REGN: Inflarx Nv has a market cap of $77.35M while Regeneron Pharmaceuticals Inc has $78.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IFRX and REGN?
IFRX (Inflarx Nv) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IFRX or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IFRX or REGN?
REGN has higher revenue growth at 0.0% vs -0.8% for IFRX.
Which company is more profitable: IFRX or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -24677.9% for IFRX.
Which is the larger company: IFRX or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.92B compared to $77.35M for IFRX.
Should I buy IFRX or REGN in 2026?
Both IFRX and REGN have investment merit. IFRX trades at $1.07 while REGN trades at $755.51. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IFRX and REGN stock?
Key differences: Market Cap ($77.35M vs $78.92B), P/E Ratio (N/A vs 18.0x), Revenue Growth (-0.8% vs 0.0%), Gross Margin (-24677.9% vs 44.6%).